User
Write something
🐎 Member Opportunity — The Reserve's No Nut November Group Buy
Another group buy worth sharing with Dark Horse members! The Reserve — Group Buy #5 Vendor: GFB Closes Sunday, November 29 Six products are being offered, with mass/identity, purity/potency, and endotoxin testing advertised as included. Available Products: - Mito Fusion — $140 - SS-31 20 mg + MOTS-C 20 mg - KLOWERINE — $180 - GHK-Cu 50 mg + KPV 20 mg + BPC-157 20 mg + TB4 20 mg - 110 mg total blend - NAD+ (Buffered) — $58 - 1,000 mg - TESA / IPA Blend — $185 - Tesamorelin 20 mg + Ipamorelin 5 mg - GHK-Cu / KPV Blend — $100 - 100 mg + 20 mg - 5-Amino-1MQ — $180 - 1,000 mg One that caught my attention is KLOWERINE. Four compounds in a single 110 mg blend, combining different research pathways involving tissue recovery, inflammation, and cellular repair. An interesting formulation, particularly for those already following GHK-Cu, KPV, BPC-157, and TB4 research. Anyone interested in splitting a kit? I'm personally interested in splitting kits of a few of these products, specifically KLOWERINE, Mito Fusion, and GHK-Cu/KPV. If anyone is interested in splitting a kit on any of these three with me please, let me know. Direct group buy order form: https://ezformz.net/f/no-nut-november Ordering Options: Orders can be placed directly through The Reserve. Alternatively, Dark Horse can handle order placement, cryptocurrency payment, and/or coordinating split kits for members who prefer that option. DH order processing and payment fee: $15.00. does not include DH shipping.
0
0
🐇 The Rabbit Hole: Are Your Hormones Really Balanced?
"Get your hormones balanced first." How many times have you heard that advice? Before starting a peptide. Before trying a GLP-1. Before addressing fatigue, stubborn body fat, poor recovery, or declining energy. Sounds reasonable, doesn't it? But what exactly does balanced mean? Think about it. A 35-year-old woman, a 48-year-old woman entering perimenopause, a 45-year-old man, and a 65-year-old man are living in four very different hormonal environments. And those environments are constantly changing. Age. Sleep. Stress. Diet. Exercise. Calorie restriction. Medications. Illness. Even the emotional challenges of everyday life. Your body doesn't operate in a laboratory under perfectly controlled conditions. You might sleep eight hours tonight and five tomorrow. Have a relatively stress-free Monday and an emotionally exhausting Tuesday. Your hormones respond to those changes. And here's another question. Who decided that falling within a laboratory's "acceptable range" means your hormones are balanced? Those ranges are useful medical reference points. But they don't necessarily tell us how well an individual feels, recovers, performs, or responds to a particular intervention. Nor does being outside an idealized youthful range automatically mean something is wrong. So, when someone says, "Don't bother with this compound until your hormones are balanced," I have to wonder: Balanced to what? Your age? Your sex? Your younger self? A laboratory reference range? Someone else's idea of optimal? Maybe we're asking the wrong question. Rather than expecting the human body to achieve some permanent state of hormonal balance, perhaps we should be looking at the biological environment we're actually living in. What's changing? What's creating stress? What's affecting our energy, recovery, metabolism, and overall well-being? And how might different interventions support that environment rather than pretending we can make every variable perfect? That doesn't mean genuine hormonal disorders should be ignored. It means normal biological variation and hormonal disease aren't the same thing.
🐎 Move Over, Retatrutide? There's a New Triple Agonist Coming!
Meet UBT251. Originally developed by a Chinese pharmaceutical company called United Laboratories (TUL), UBT251 caught the attention of Novo Nordisk, the company behind Ozempic and Wegovy. In March 2025, Novo Nordisk secured the rights to develop and market UBT251 outside Greater China. So what's the excitement about? Like Retatrutide, UBT251 targets three receptors: - GLP-1 — helps regulate appetite and blood sugar. - GIP — influences insulin response and metabolism. - Glucagon — plays a role in energy expenditure and fat metabolism. In a Phase 2 obesity study involving 205 participants, the highest-performing UBT251 treatment group reportedly achieved 19.7% average weight loss in just 24 weeks. That's certainly enough to get researchers' attention! And here's where things get interesting for the peptide research community. We're already seeing early signs of gray-market resellers preparing to introduce UBT251 into their storefronts. I'm aware of at least one U.S. research vendor having announced that its evaluating UBT251, with testing and product specifications still being finalized. That tells us the gray-market supply chain is beginning to move, even as pharmaceutical development continues. Will UBT251 outperform Retatrutide? Too early to tell. They're different molecules targeting the same three receptor families, and their real-world responses may differ considerably. But one thing is becoming clear: Retatrutide may soon have some serious competition, both in pharmaceutical research and in the independent peptide marketplace. And UBT251 isn't the only newcomer worth watching. We're also seeing CBL-514 begin entering the gray market. Unlike UBT251 and Retatrutide, which work throughout the body, CBL-514 is being investigated for localized fat reduction by targeting fat cells in specific areas. A recent CBL-514 group buy closed with 116 orders against an MOQ of 50. Even more interesting, Janoshik is reportedly developing an entirely new testing methodology for CBL-514, with an initial testing cost of $1,100, excluding product vials and international shipping.
1
0
🐎 Move Over, Retatrutide? There's a New Triple Agonist Coming!
🐎 DARK HORSE — THE FINAL CHAPTER
Peptides: Out of the Shadows After considerable thought, I've made the decision to permanently close Dark Horse — Peptides: Out of the Shadows. Our anticipated closure is potentially by November 30, 2026, once all outstanding orders have been received and shipped. No additional group buys or new orders will be accepted. WHY I'VE MADE THIS DECISION When I created Dark Horse, my vision was to build something more than another peptide buying group. I wanted a community of curious, engaged individuals who were interested in exploring the science, challenging assumptions, exchanging knowledge, and contributing to meaningful discussions. Over the past year, I've invested countless hours researching complicated subjects, preparing educational deep dives, investigating independent laboratory testing, evaluating emerging compounds, and organizing group buys. Unfortunately, the level of member participation and engagement never developed into what I had hoped or envisioned. Despite the amount of information shared and the opportunities provided, meaningful participation has consistently come from a very small percentage of our membership. To those individuals — and you know who you are — I want to extend my sincere appreciation and thanks for your contributions, involvement, and support in helping Dark Horse develop over this past year. Your participation did not go unnoticed, and I am genuinely grateful. A community, at least in my view, should be more than a place where information is posted and passively consumed. It should be a place where members exchange ideas, ask questions, challenge findings, and contribute to the collective knowledge. That simply hasn't happened to the degree I had hoped. I certainly don't expect everyone to participate in every discussion. But maintaining a research-focused community requires more than the efforts of one individual. At this point, I've concluded that continuing to invest substantial time and energy into something that hasn't developed the collaborative environment I envisioned no longer makes sense.
🔬 TOPICAL COPPER PEPTIDES | VANGUARD RESEARCH
A few interesting skincare options from Vanguard Research featuring GHK-Cu and AHK-Cu. Products include hair serum, face serum, under-eye solution, and raw copper peptide powders for DIY formulations. Prices range from $9 to $28, plus shipping. See attached graphics for ingredients, concentrations, and pricing. Interested? Contact @vanguard1 on Telegram for ordering details. Outside vendor offering — not DH inventory or a DH promotion.
1
0
🔬 TOPICAL COPPER PEPTIDES | VANGUARD RESEARCH
1-30 of 324
powered by
Peptides: Out of the Shadows
skool.com/monument-method-2583
Your Body. Your Code.
The science is out. The code is yours to write.
A place to share real peptide experiences and see what’s actually working.
Build your own community
Bring people together around your passion and get paid.
Powered by